Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
4.150
+0.110 (2.72%)
Sep 29, 2026, 4:00 PM EDT - Market closed
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $10.9 million as of September 29, 2026. Its market cap has increased by 45.30% in one year.
Market Cap
10.90M
Enterprise Value
-17.81M
1-Year Change
45.30%
Ranking
Category
Stock Price
$4.15
ChartMarket Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.30M to $10.90M, a decrease of -58.56%. That is a compound annual growth rate of -10.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 10.90M | 105.66% |
| Dec 31, 2025 | 5.30M | -18.46% |
| Dec 31, 2024 | 6.50M | 182.61% |
| Dec 29, 2023 | 2.30M | -60.34% |
| Dec 30, 2022 | 5.80M | -89.66% |
| Dec 31, 2021 | 56.10M | 131.82% |
| Dec 31, 2020 | 24.20M | -2.81% |
| Dec 31, 2019 | 24.90M | -25.89% |
| Dec 31, 2018 | 33.60M | 27.76% |
| Jul 30, 2018 | 26.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 11.47M |
| Daré Bioscience | 11.47M |
| Moleculin Biotech | 11.08M |
| BioLineRx | 11.08M |
| MetaVia | 11.04M |
| CytoMed Therapeutics | 10.95M |
| Purple Biotech | 10.63M |
| Azitra | 10.27M |